F32 F33
Conditions
Interventions
Group 1: Observationgroup 1: Non-depressed patients. For details see Primary and Secondary Outcome above.
Group 2: Observationgroup 2: Depressed patients. For details see Primary and Secondary Outcome
Sponsors
Klinik für Psychiatrie und Psychotherapie, Campus Charité Mitte, Charité - Universitätsmedizin Berlin
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: Ability to give consent, written consent
Exclusion criteria
Exclusion criteria: Antisocial personality disorder, severe cognitive limitations e.g. dementia or severe intellectual disability, withdrawal of the declaration of consent
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Depressive symptoms measured with the Patients Health Questionnaire (PHQ-8). Other measuring instruments: Generalized Anxiety Disorder 7 (GAD-7); Patient Health Questionnaire 15 as somatic symptoms subscale (PHQ-15); Patient Health Questionnaire Stress; Child Trauma Questionnaire (CTQ); Gender minority an resilience measure (GMSR); Rosenberg Self-Esteem Scale (RSES); Self-Rated Successful Aging (SRSA); Internalized Homonegativity Inventory (IHNI); Homopositivity Scale (HPS); Internalized transphobia of the Transgender Identity Survey (TIS-8); Social Support Questionnaire (SSQ6); HIV Stigma-Revision Scale (HIV-Stigma-Revision-12); Community Connectedness from Gender minority an resilience measure (GMSR); Everyday Discrimination Scale (EDS); Resilience Scale (RS10); Internale-Externale-Kontrollu¨berzeugung-4 (IE-4); Big-Five-Inventory-10 (BFI-10); A 6-Item Scale for Overall; Emotional, and Social Loneliness Confirmatory Tests on Survey Data; 8-item index based on the World Health Organization Quality of Life Assessment (Eurohis-QOL); WHO-Five Well-Being Index (WHO-5); Leipzig questionnaire of motives to have a child (LKM). | — |
Secondary
| Measure | Time frame |
|---|---|
| As secondary Outcome collected: blood samples for neurobiological factors such as cytokine, saliva samples and hair samples for cortisol analysis. The aim is to generate a sufficiently large and diverse biobanking for the analysis of group differences. | — |
Countries
Germany
Contacts
Public ContactMaximilian Berger
Charité - Universitätsmedizin Berlin Psychiatrische Universitätskliniken der Charité im St. Hedwig-Krankenhaus
Outcome results
None listed